PD-(L)1 Inhibitors Versus Chemotherapy Versus Their Combination in Front-line Treatment for NSCLC: An Indirect Comparison

    Hengrui Liang
    Hengrui Liang
    Zhichao Liu
    Zhichao Liu
    Xiuyu Cai
    Xiuyu Cai
    Zhenkui Pan
    Zhenkui Pan
    Difei Chen
    Difei Chen
    Caichen Li
    Caichen Li
    Yingying Chen
    Yingying Chen
    Jianxing He
    Jianxing He

    International journal of cancer, 2019.

    被引用0|引用|浏览0|来源
    WOS
    关键词
    NSCLCPD-1/L1 inhibitorschemotherapy

    摘要

    We comprehensively compared the therapeutic effects and safety of PD-1/L1 antibodies (I), chemotherapy (C) or their combination (I+C) as first-line treatments for advanced NSCLC. Online databases were searched to identify RCTs. Survival outcomes and safety events were pooled by indirect treatment comparison. Main subgroup analyses were co...更多

    代码

    数据

    您的评分 :
    0

     

    标签
    评论